Discovery of a Class of Diketopiperazines as Antiprion Compounds
Authors:
- Maria Laura BolognesiMBMaria Laura Bolognesi
- Matteo StaderiniMSMatteo Staderini
- Alessandra MonacoAMAlessandra Monaco
- Alberto López‐CobeñasALAlberto López‐Cobeñas
- Salvatore BongarzoneSBSalvatore Bongarzone
- Pilar López‐AlvaradoPLPilar López‐Alvarado
- Nieves CabezasNCNieves Cabezas
- Maria CaramelliMCMaria Caramelli
- Paolo CarloniPCPaolo Carloni
- J. Carlos MenéndezJ. Carlos Menéndez
- 23 July 2010
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 5 (8) , 1324-1334
Abstract
Prion diseases are fatal neurodegenerative and infectious disorders for which effective pharmacological tools are not yet available. This unmet challenge and the recently proposed interplay between prion diseases and Alzheimer's have led to a more urgent demand for new antiprion agents. Herein, we report the identification of a novel bifunctional diketopiperazine (DKP) derivative 1 d, which exhibits activity in the low micromolar range against prion replication in ScGT1 cells, while showing low cytotoxicity. Supported by properly addressed molecular modeling studies, we hypothesized that a planar conformation is the major determinant for activity in this class of compounds. Moreover, studies aimed at assessing the mechanism‐of‐action at the molecular level showed that 1 d might interact directly with recombinant prion protein (recPrP) to prevent its conversion to the pathogenic misfolded prion protein (PrPSc)‐like form. This investigation suggests that DKP based antiprion compounds can serve as a promising lead scaffold in developing new drugs to combat prion diseases.Keywords
This publication has 56 references indexed in Scilit:
- Therapeutic strategies against protein misfolding in neurodegenerative diseasesExpert Opinion on Drug Discovery, 2008
- Structural Basis of Infectious and Non-Infectious AmyloidsCurrent Alzheimer Research, 2008
- Prions and prion diseasesThe FEBS Journal, 2007
- Prions and their partners in crimeNature, 2006
- A systematic review of prion therapeutics in experimental modelsBrain, 2006
- Evidence for assembly of prions with left-handed β-helices into trimersProceedings of the National Academy of Sciences, 2004
- Protein folding and misfoldingNature, 2003
- Neurodegenerative Diseases and PrionsNew England Journal of Medicine, 2001
- Conformational diseaseThe Lancet, 1997
- Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. III. Structure-activity relationships.The Journal of Antibiotics, 1988